temozolomide has been researched along with carbocyanines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, PJ; Cooper, E; Denny, WA; Dragunow, M; Faull, R; I-H Park, T; Jose, J; Mee, E; Schweder, P; Turner, C | 1 |
| Chen, Q; Jiang, T; Qian, R; Qiao, Y; Ruan, W; Shi, B; Wang, G; Yang, Q; Yin, J; Zhang, D; Zheng, M; Zhu, F; Zou, Y | 1 |
| Mahajan, SD; Pliss, A; Prasad, PN; Schmitt, RR | 1 |
3 other study(ies) available for temozolomide and carbocyanines
| Article | Year |
|---|---|
Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines.
Topics: Antineoplastic Agents; Brain Neoplasms; Carbocyanines; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Design; Drug Repositioning; Drug Therapy, Combination; Glioblastoma; Humans; Indoles; Molecular Structure; Piperidines; Temozolomide | 2021 |
Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy.
Topics: Acrylic Resins; Animals; Blood-Brain Barrier; Carbocyanines; Cations; Cell Line, Tumor; Drug Carriers; Glioblastoma; Humans; Mice; Micelles; Nanomedicine; Nanoparticles; RNA Interference; RNA, Small Interfering; STAT3 Transcription Factor; Temozolomide; Tissue Distribution; Transplantation, Heterologous | 2021 |
Small molecule based EGFR targeting of biodegradable nanoparticles containing temozolomide and Cy5 dye for greatly enhanced image-guided glioblastoma therapy.
Topics: Brain Neoplasms; Carbocyanines; Cell Line, Tumor; ErbB Receptors; Glioblastoma; Humans; Nanoparticles; Temozolomide | 2022 |